Thieno[2,3-d]pyrimidinones as Potent Antitumor Agents: Mechanistic Insights into BRAF/MEK/ERK Pathway Suppression and Melanoma Selectivity

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Heba El-Sayed Teba, Inas G. Shahin, Amr Abdelhamid, Mai A. Zaafan, Aliaa M. Kamal, Ahmed A. M. Ibraheem
DOI: 10.2139/ssrn.6296599
Cited by: 0

Fields of Study & Subjects

Heterocyclic Compound Synthesis and Bioactivity Melanoma and MAPK Pathways Synthesis and Characterization of Heterocyclic Compounds

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Language
EN
Document type
Preprint